Showing 4,241 - 4,260 results of 4,407 for search '"pharmaceutical"', query time: 0.09s Refine Results
  1. 4241
  2. 4242
  3. 4243
  4. 4244

    Antimicrobial Usage in Smallholder Poultry Production in Nigeria by Oladeji Bamidele, Tunde A. Amole, Oluwafikayo A. Oyewale, Olayinka O. Bamidele, Abdulmojeed Yakubu, Uduak E. Ogundu, Folasade O. Ajayi, Waheed A. Hassan

    Published 2022-01-01
    “…The western method (pharmaceuticals) was practiced by a large proportion of farmers (60%), either solely (25%) or in combination with EVM (35%). …”
    Get full text
    Article
  5. 4245

    A Review of Current Issues Underlying Colon Cleansing before Colonoscopy by Lawrence C Hookey, Stephen Vanner

    Published 2007-01-01
    “…The present review examines four current issues related to the efficacy, patient tolerance and safety of the following bowel cleansing agents: oral sodium phosphate (NaP), polyethylene glycol (PEG) and magnesium citrate (Pico-Salax, Ferring Pharmaceuticals Inc, Canada), an agent recently made available in Canada. …”
    Get full text
    Article
  6. 4246

    Comparison of the Efficiency of Ultraviolet/Zinc Oxide (UV/ZnO) and Ozone/Zinc Oxide (O3/ZnO) Techniques as Advanced Oxidation Processes in the Removal of Trimethoprim from Aqueous... by Moayede Taie, Abdolmajid Fadaei, Mehraban Sadeghi, Sara Hemati, Gashtasb Mardani

    Published 2021-01-01
    “…Nowadays, advanced oxidation processes, particularly photocatalyst process and catalytic ozonation by ZnO nanoparticles, are the most efficient method of eliminating pharmaceuticals. The purpose of this study was to compare the efficiency of ultraviolet/zinc oxide (UV/ZnO) and ozone/zinc oxide (O3/ZnO) techniques as advanced oxidation processes in the removal of trimethoprim (TMP) from aqueous solutions. …”
    Get full text
    Article
  7. 4247

    Risk characterisation of chemicals of emerging concern in real-life water reuse applications by Jan C. Specker, Antonia Praetorius, Milo L. de Baat, Nora B. Sutton, Annemarie P. van Wezel

    Published 2025-01-01
    “…However, a thorough risk assessment of CECs during water reuse is currently limited due to a focus on a defined class of contaminants in the literature, i.e., pharmaceuticals, and falls short of per- and polyfluoroalkyl substances. …”
    Get full text
    Article
  8. 4248

    Occurrence of Acetaminophen, Amoxicillin, Diclofenac and Methylparaben in Lagos and Ologe Lagoons, Lagos, Nigeria by O.S. Folarin, A.A. Otitoloju, N.H. Amaeze, J.K. Saliu

    Published 2020-01-01
    “…The study established that there are active pharmaceuticals compounds and excipients present in the Nigerian aquatic environment which are  micropollutants of emerging environmental concerns and of significant ecological risk. …”
    Get full text
    Article
  9. 4249

    Impact of fluoxetine exposure on Lymnaea stagnalis and its developing eggs: integrating untargeted lipidomics, targeted metabolomics, and classical risk assessment by Diana Ilyaskina, Yumi Nakadera, Yumi Nakadera, Marja H. Lamoree, Joris M. Koene, Pim E. G. Leonards

    Published 2025-02-01
    “…Pharmaceuticals such as selective serotonin reuptake inhibitors (SSRIs), are increasingly detected in aquatic environments, posing potential risks to non-target organisms, because many of those substances are widely shared neuromodulator. …”
    Get full text
    Article
  10. 4250

    Occurrence of Acetaminophen, Amoxicillin, Diclofenac and Methylparaben in Lagos and Ologe Lagoons, Lagos, Nigeria by O.S. Folarin, A.A. Otitoloju, N.H. Amaeze, J.K. Saliu

    Published 2020-01-01
    “…The study established that there are active pharmaceuticals compounds and excipients present in the Nigerian aquatic environment which are  micropollutants of emerging environmental concerns and of significant ecological risk. …”
    Get full text
    Article
  11. 4251

    Telaprevir in treatment of chronic hepatitis C: safety issues by T. M. Ignatova

    Published 2012-07-01
    “…Special attention is given to prophylaxis of interactions with other pharmaceuticals, as telaprevir is P450 (СYP) 3A4 substrate and inhibitor and P-glycoprotein transporter.Conclusion. …”
    Get full text
    Article
  12. 4252

    High Stability Single-Port Dual Band Microwave Sensor Based on Interdigital Capacitor Structure With Asymmetry Branch Feedline by Syah Alam, Indra Surjati, Lydia Sari, Raden Deiny Mardian, Teguh Firmansyah, Muhammad Iqbal, Slamet Widodo, Mudrik Alaydrus, Zahriladha Zakaria

    Published 2025-01-01
    “…Therefore, this sensor can be recommended for several applications such as biomedical industry, pharmaceuticals and material quality control especially for outdoor measurements that are potentially affected by electromagnetic interference and disturbance.…”
    Get full text
    Article
  13. 4253

    Microalgae-based bioremediation of refractory pollutants: an approach towards environmental sustainability by Mostafa M. El-Sheekh, Hala Y. El-Kassas, Sameh S. Ali

    Published 2025-01-01
    “…Therefore, this review discusses the mechanism and the ability of different microalgal species to mitigate persistent refractory pollutants, such as industrial effluents, dyes, pesticides, and pharmaceuticals. Also, this review paper provided insight into the production of nanomaterials, nanoparticles, and nanoparticle-based biosensors from microalgae and the immobilization of microalgae on nanomaterials to enhance bioremediation process efficiency. …”
    Get full text
    Article
  14. 4254

    Bridging Molecular Docking to Molecular Dynamics to Enlighten Recognition Processes of Tailored D-A/D-A-D Types' AIEgens with HSA/BSA by Harun Nalçakan, Gülbin Kurtay

    Published 2023-09-01
    “…In this scope, we performed a detailed molecular dock-ing study of Donor (D)-Acceptor (A) or D-A-D type luminogens with two blood proteins; namely bovine serum albumin (BSA) and human serum albumin (HSA), which appeared as robust carriers of several pharmaceuticals against preliminary cancer diseases. Our results revealed that the binding scores of the Dn-An or Dn-An-Dn:BSA complexes ranged from -8.5 to -11.7 kcal/mol while Dn-An or Dn-An-Dn:HSA complexes showed scores varying from -8.4 to -10.5 kcal/mol. …”
    Get full text
    Article
  15. 4255

    The Burden of Cost in Bronchiolitis Obliterans Syndrome: Predictions for the Next Decade by Christopher A. Jones, David G. Chapman, Peter Weimersheimer, Luca Fernandez, Oscar Alejandro Mesa, Christian Peters, Bart M. Vanaudenaerde, Mitchell C. Norotsky, Robin Vos

    Published 2016-06-01
    “…., hospitalizations, pharmaceuticals, devices), and non-medical direct costs such as monitoring and professional caregiving. …”
    Get full text
    Article
  16. 4256
  17. 4257
  18. 4258
  19. 4259
  20. 4260